1. Main page
  2. Biotechnology
  3. Axxam

Axxam

3 Decision Makers · 5 Verified Contacts

axxam.com
📍 Milan, Lombardia, ItalyBiotechnology🗓 Est. 2001👥 51–100 employees

About Axxam

Axxam is focused on the development of small molecule drugs with the ability to target inflammation directly.

Leadership & Decision Makers

Contact details of 3 Axxam decision makers

Stefan Lohmer

Co-Founder, Chairman and CEO

Luigi Gavazzeni

Chief Financial Officer

Alessandro Sidoli

Co-Founder and CEO

Team & Specialists

Contact details of 2 Axxam team members

Rebecca Steele

  • Work email

    r***************s@axxam.com

Sara Santangelo

  • Work email

    s****************s@axxam.com

General Emails

General company emails, e.g. customer support lines

    info@axxam.com

    General Inquiries

    suzanne.beveridge.sb@axxam.com

    Unclassified inbox

    alessandro.sidoli.as@axxam.com

    Unclassified inbox

    request@axxam.com

    Unclassified inbox

Verify Axxam Emails

Similar Companies like Axxam

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Vertex Pharmaceuticals

vrtx.com
Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 31/07/2025

axxam.com

0039-022105609

Milan, Lombardia, Italy

Legal Name: Axxam S.p.A.
Business Type: Private
Employees: 51-100
Rounds: Grant
Founded Date: 2001
Company Type: For Profit
Operating Status: Active
Last Funding Type: Grant
Phone Number: 0039-022105609
Last Investment Activity: Dec 22, 2023
Investments Activity: Dec 22, 2023 Mar 29, 2023 Jul 6, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.